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The ability of [‘Z51]calreticulin to bind to membrane fractions isolated from different muscle and non-muscle tissues was examined by a protem 
overlay technique. Specific [‘251]calreticulin b ding proteins were detected in rat liver smooth and rough endoplasmic reticulum and Golgi, in canme 
pancreatic microsomes, and in rabbit skeletal muscle sarcoplasmic reticulum. These proteins were confined only to membranes that contam 
calreticulin; they were not found in rat liver mitochondria or cytosol. [‘2SI]Calreticulin binds to a 50-kDa protein and a number of lower M, 
(20,000-38,000) endoplasmic reticulum membrane proteins and to 30-kDa protein in skeletal muscle sarcoplasmic reticulum. Full-length calrettculin 
and the carboxyl-terminal region (C-domain) of the protein both competed with [“51]calreticulin for binding to the membrane proteins. Bmdmg 
of [‘2SI]calreticulin to pancreatic microsomes was also partially inhibited by the N-domam and to a lesser extent by the P-domurn of the protein. 
We conclude that calreticulin interacts with the endoplasmic reticulum membrane proteins mainly through its carboxyl-terminal domain and that 
the endoplasmic and sarcoplasmic reticulum membranes may contain different calreticulin binding proteins. 
Calreticulin; Calcium binding protein; Endoplasmic reticulum; Sarcoplasmic reticulum; Protein overlay 
1. INTRODUCTION 
Calreticulin is a major Ca2’-binding, peripheral mem- 
brane protein of the lumen of the ER (for review see [l]). 
Calreticulin is also localized to the nuclear envelope in 
a variety of cells and to the nucleus in L6 cells [2]. Based 
on the ability of calreticulin to bind >25 mol of Ca’+/ 
mol of protein [3,4], it has been proposed that calretic- 
ulin may play a Ca2’ storage role in the ER [l]. This is 
analogous to calsequestrin, the main Ca*’ storage pro- 
tein of skeletal muscle SR [5]. Recent reports indicate 
that calreticulin may interact with different cellular pro- 
teins and thus have more than one cellular function [l]. 
In this study, to determine if calreticulin associates 
with other components of the ER membranes, we have 
employed a protein overlay (ligand blotting) technique. 
Using this technique we have detected proteins that 
interact with calreticulin in rat liver ER, Golgi mem- 
branes and the nucleus, in canine pancreatic micro- 
somes, and in rabbit skeletal muscle SR. Interaction 
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with these proteins is mediated mainly through the C- 
domain of calreticulin. 
2. EXPERIMENTAL PROCEDURES 
Pancreatic microsomes were isolated by the procedure described by 
Walter and Blobel [6]. Smooth and rough ER, Golgi, nuclei and the 
cytosolic fractions were isolated from rat liver as described by Croze 
and Morre [7]. SR membrane fractions were isolated from rabbit 
skeletal muscle [8]. Initial tissue homogenizations and subsequent 
membrane fractionations were performed in the presence of a mixture 
of the protease inhibitors [9]. Isolated membrane vesicles were frozen 
in liquid N2 and stored at -85°C. Protein was determined by the 
method of Lowry et al. [lo]. 
Calreticulin was purified from dog pancreas by a selective ammo- 
nium sulfate precipitation method [ll]. Recombinant full-length cal- 
reticulin and the domains of calreticulin were expressed in E. colr as 
glutathione S-transferase (GST) fusion proteins and purified [4,11]. 
Iodination of the native and recombinant calreticulin was carried out 
using Iodo-Gen (Pierce Chemical Co.) as described by Beisiegel et al. 
1121. 
SDS-PAGE (10% acrylamide) was carried out as described by 
Laemmh 1131. After gel electrophoresis, proteins were transferred elec- 
trophoretically onto nitrocellulose membrane according to the method 
of Towbin et al. [14]. Transferred proteins were visualized with Pon- 
ceau-red, which did not affect [‘2SI]calreticulin binding to the blots. 
Before incubation with [‘251]calreticulin, thenitrocellulose blots were 
preincubated for 1 h in blocking buffer containing 20 mM Tris, 150 
mM KCI, 5% bovine serum albumin and either 2 mM ZnSO,, 5 mM 
CaCl, or 5 mM EGTA. [‘251]Calreticuhn (lo6 cpmlml) was added to 
freshly prepared blocking buffer and incubated with the nitrocellulose 
strips for 2 h at room temperature. The blots were rinsed 3 times with 
blocking buffer, followed by two 30 min washes in blocking buffer. In 
competition experiments unlabeled proteins were added at a concen- 
tration of 1 mg/ml. Dried nitrocellulose filters were exposed to Kodak 
XAR-5 film. Standards were Bio-Rad low range molecular weight 
proteins or Bio-Rad prestained markers. 
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Fig. 1. SDS-PAGE and binding of ‘251-labeled calreticulin to pancre- 
atic membrane proteins. Pancreatic microsomal membranes were sub- 
jected to SDS-PAGE, transferred to nitrocellulose and analyzed by 
ligand blotting with ‘2SI-labeled calreticulin as described under the 
Experimental Procedures. Lane S, Bio-Rad low range molecular 
weight markers; lane 1, Coomassie blue staining of pancreatic micro- 
somes; lane 2, autoradiographs of [“51]calreticulin binding proteins in 
pancreatic microsomes. Lane 1, 30 /lg of protein, lane 2. 80 ,Ug of 
protein. Arrowheads indicate calreticulin bindmg proteins. 
3. RESULTS 
Seven major proteins were consistently detected that 
interacted with [lZSI]calreticulin in pancreatic mem- 
branes; a protein doublet at 50- and 52-kDa, and a 
series of lower molecular weight proteins ranging from 
38,000 to 20,000 (Fig. 1, lanes 2, arrowheads). Though 
calreticulin is a Ca’+ and Zn”’ binding protein [l], the 
binding of [“‘I]calreticulin to the microsomal proteins 
on the nitrocellulose blots was neither Ca’+ nor Zn’+ 
dependent (data not shown). Excess of unlabeled cal- 
reticulin competed with [“‘I]calreticulin for binding to 
the proteins of the pancreatic microsomes (Fig. 2). 
To establish which region of calreticulin was respon- 
sible for the observed interactions, the N-, P- and C- 
domains [l] were used in competition experiments. The 
GST-C-domain, but not GST alone, efficiently com- 
peted with [“SI]calreticulin for binding to pancreatic 
microsomal proteins (Fig. 3, lanes D and E). The GST- 
N-domain partially inhibited [“‘I]calreticulin binding to 
the membrane proteins (Fig. 3, lane B). The GST-P- 
domain had little effect on [‘251]calreticulin binding and 
only partially inhibited [“‘I]calreticulin binding to the 
50-kDa doublet protein band (Fig. 3, lane C). There- 
fore, calreticulin appears to interact with these proteins 
mainly via its carboxyl-terminal region (C-domain). 
Calreticulin has been localized to the ER membranes, 
nuclear envelope and in L6 cells to the nucleus [2,15]. 
Fig. 4A shows that [“51]calreticulin interacts with a sim- 
ilar set of proteins in rat liver microsomes (lane l), liver 
smooth and rough ER (lanes 2 and 3) and Golgi (lane 
4). In contrast, in the nucleus three proteins of 35-kDa, 
33-kDa and 30-kDa were detected (Fig. 4A, lane 8). A 
major difference between the pattern of calreticulin 
binding proteins in smooth and rough ER was that in 
the former the 52-kDa protein band was not labeled 
(Fig. 4A, lane 2). It is difficult to establish if the labeling 
pattern found in smooth ER membranes corresponds to 
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Fig. 2. Inhibition of binding of [‘ZSI]calreticulin to pancreatic microsomes by unlabeled calreticulm. Different amounts of pancreatic microsomal 
proteins were subjected to SDS-PAGE followed by transfer to nitrocellulose and by an overlay with a “51-labeled calreticulin in the absence (A) 
01 presence (Bj of unlabeled calreticulin (1 mg/ml). The positions of Bio-Rad prestained molecular mass standards are indicated. 
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Fig. 3. C-domain of calreticulin inhibits binding of ‘2SI-labeled calreticulin to pancreatic microsomes. Pancreatic microsomes (80 pug of protein) were 
subjected to SDS-PAGE followed by transfer to nitrocellulose. Lane A, overlay with a ‘*‘I-labeled calreticulin; lanes B, C and D [‘251]ca1reticu1in 
overlay were carried out in the presence of 1 mg/ml of the GST-N-&mum, GST-P-domain and GST-C-domain, respectively. Lane E, [‘*‘I]calreticulin 
overlay in the presence of GST (1 mg/ml). The positions of Bio-Rad prestained molecular mass standards are indicated. 
the true smooth ER membrane or contaminations de- 
rived from the rough ER. The smooth ER fraction used 
in this study consists of a mixture of smooth ER mem- 
branes and rough ER membrane from which ribosomes 
have become dissociated during the isolation [7]. Fig. 
4A, lanes 5-7 also shows binding of [‘251]calreticulin to 
skeletal muscle SR membrane proteins. A protein band 
of 30-kDa was the major [1251]calreticulin b ding pro- 
tein in the heavy and light SR membranes. Smaller 
quantities of a 90-kDa and 50-kDa protein also bound 
[‘2SI]calreticulin these SR membranes (Fig. 4A, lanes 
5-7). 
To establish the specificity of our ligand binding 
method we also tested subcellular fractions that are 
known not to contain any immunologically detectable 
calreticulin, i.e. mitochondria and cytosol [2,15]. Fig. 
4B shows that [‘251]calreticulin does not bind to mito- 
chondrial (Fig. 4B, lane 2) or cytosolic (Fig. 4B, lane 3) 
proteins isolated from rat liver. In addition, there was 
only one protein (- 33-kDa) detected when a large 
amount (>200 ,ug protein/lane) of E. coli cellular extract 
was tested for [1251]calreticulin b ding (Fig. 4B, lane 5). 
[“SI]Calreticulin did not bind to the purified, unlabeled 
calreticulin (Fig. 4B, lane 4). 
4. DISCUSSION 
Using a protein overlay technique we have detected 
a set of proteins that bind [12SI]calreticulin in rat liver 
ER, Golgi, canine pancreatic microsomes (predomi- 
nantly rough ER), nuclei and in rabbit skeletal muscle 
SR. In non-muscle ER membranes, native or recombi- 
nant [“51]calreticulin binds to a 50- and 52-kDa protein 
band doublet and a number of lower M, (38-20-kDa) 
proteins. In contrast, muscle SR membranes contain 
only one major calreticulin binding protein of M, 
- 30 000. Full-length calreticulin com- 
peted with [“51]calreticulin for binding to the membrane 
proteins. We have shown here that the calreticulin bind- 
ing proteins were confined only to the membranes that 
contain calreticulin: they were not found in rat liver 
mitochondria or cytosol, and they were identified only 
in small amounts in the skeletal muscle SR. 
Ligand binding (blotting) method is a simple yet pow- 
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Fig. 4. Binding of ‘251-labeled calreticulin to different membrane fractions. (A) Lane 1. rat liver microsomes; lane 2, rat liver smooth ER; lane 3, 
rat liver rough ER; lane 4, rat liver Golgi membranes; lane 5, rabbit skeletal muscle light SR membrane; lane 6, rabbit skeletal muscle heavy SR 
membrane; lane 7, rabbit skeletal muscle microsomes, lane 8, rat liver nuclei. (B) Lane 1, pancreatic microsomes; lane 2, rat liver mitochondria; 
lane 3, rat liver cytosolic proteins (100,000 x g supematant); lane 4, purified, recombinant calreticulin; lane 5, E. coli cellular extract. The positions 
of Bio-Rad prestained and low range molecular mass standards are indicated. 
erful technique to identify protein-protein interactions overlay) method for the identification of calsequestrin 
It has been used in the past to identify calmodulin bind- binding protein(s) in cardiac SR membranes. They iden- 
ing protein [16], low density lipoprotein receptor [ 171 tified a 26kDa calsequestrin-binding protein in that 
and calsequestrin binding proteins [ 18,191. Calse- membrane system. Recently, Damiani and Margreth 
questrin and calreticulin share some basic functional [l S] have described a set of calsequestrin binding pro- 
similarities, as both proteins are considered to be Ca” teins (47-kDa: 31-30-kDa, 29-kDa and 26-25-kDa) in 
binding (storage) sites in the lumen of muscle SR and skeletal muscle SR membrane. Calsequest~n interacts 
non-muscle ER membranes, respectively [151. Mitchell with these SR membrane proteins in a Ca”-dependent 
et al. 1191 was first to empIoy ligand binding (protein manner 118,191. A 30-kDa calreticulin binding protein 
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identified in this study in the SR membranes may corre- 
spond to the 26kDa calsequestrin binding protein iden- 
tified by Mitchell et al. [19]. 
Calreticulin can be divided into three structurally dif- 
ferent regions referred to as N-, P- and C-domain that 
may perform different functions [I]. For example, the 
high affinity and the low affinity Ca’+ binding sites are 
localized to the P-domain and C-domain, respectively 
[4]. Although the N- and P-domains may contribute to 
[‘251]calreticulin binding to microsomal proteins, the C- 
terminal region (C-domain) is likely the main region 
involved in the observed protein-protein interactions. 
This region of the protein is relatively acidic and has 
been proposed to exist in an extended conformation [I 1. 
The involvement of the carboxyl-terminal region of cal- 
reticulin in protein-protein interactions may be signifi- 
cant in regards to a recent observation. Wada et al. [20] 
cloned an integral membrane protein of the ER (named 
calnexin) which shows marked similarity to calreticulin 
in its amino acid sequence. The highest similarity be- 
tween the two proteins is confined to the P- and C- 
domain of calreticulin. The carboxyl-terminal region of 
calnexin (‘C-domain’) has been proposed to be exposed 
to the cytoplasmic site of the ER membranes. We 
showed that the C-domain of calreticulin is involved in 
protein-protein interactions, suggesting that this region 
of calnexin may also interact with other proteins. Based 
on recent observations 121-231 it was proposed that 
calnexin may function as a molecular chaperone and 
play a role in the folding and/or assembly of newly 
synthesized polypeptide chains. It is possible, therefore, 
that calreticulin, a Ca2+ binding (storage) protein, inter- 
acts with other cellular proteins and may also play a 
chaperon-like role in the lumen of the endoplasmic 
reticulum. 
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